Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Why Intuitive Surgical Stock Was Pulling Back Today
Shares of Intuitive Surgical (NASDAQ: ISRG) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates,
Intuitive Surgical (ISRG) Q4 2024 Earnings Call Transcript
Intuitive Surgical (NASDAQ: ISRG) Q4 2024 Earnings Call Jan 23, 2025, 4:30 p.m. ET Good day, and thank you for standing by. Welcome to the Q4 2024 Intuitive earnings conference call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded.
Intuitive Surgical price target raised to $666 from $640 at Truist
Truist analyst Richard Newitter raised the firm’s price target on Intuitive Surgical (ISRG) to $666 from $640 and keeps a Buy rating on the
Intuitive Surgical (ISRG) Gets a Buy from Truist Financial
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Intuitive Surgical (ISRG – Research Report), with a
Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?
Shares of robotic surgery pioneer Intuitive Surgical (NASDAQ: ISRG) have been soaring lately. Intuitive Surgical's recent performance and forward outlook are outstanding, and investors have noticed. Is it still a good time to buy Intuitive Surgical,
Intuitive Surgical stock holds as Oppenheimer keeps Perform rating
Oppenheimer maintained a Perform rating on Intuitive Surgical shares (NASDAQ:ISRG), following the company's release of its fourth-quarter results for 2024. The medical device company, currently valued at $217 billion and rated "GREAT" by InvestingPro's Financial Health Score,
Intuitive Surgical (ISRG) Gets a Hold from Evercore ISI
Evercore ISI analyst Vijay Kumar maintained a Hold rating on Intuitive Surgical (ISRG – Research Report) today and set a price target of
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say
Intuitive Surgical, Inc. (ISRG) reported $2.41 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 25.2%. EPS of $2.21 for the same period compares to $1.
10h
These Analysts Boost Their Forecasts On Intuitive Surgical Following Strong Q4 Results
Intuitive Surgical reported fourth-quarter revenue of $2.41 billion, beating the consensus estimate of $2.25 billion. The ...
8d
What's Happening With ISRG Stock?
This strong performance for Intuitive Surgical was driven by its new system – da Vinci 5 – launched last year.
MassDevice
18h
Intuitive stock slips after company warns of potential tariff impact
Intuitive's sales and profits exceeded expectations, but a warning about Trump's import tax proposal may have worried ...
3d
Here's How Much $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth Today
Intuitive Surgical ISRG has outperformed the market over the past 20 years by 19.56% on an annualized basis producing an ...
1d
on MSN
Intuitive Surgical beats quarterly profit estimates on strength in surgical robots business
Intuitive Surgical beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its surgical robots used in minimally invasive procedures.
4d
Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
Intuitive Surgical's strong revenue growth and new product rollouts drive share price surge, but investors should be cautious ...
12h
Intuitive Surgical: Strong Financial Performance and Promising Growth Prospects Make it a Buy
Lee Hambright, an analyst from Bernstein, maintained the Buy rating on Intuitive Surgical (ISRG – Research Report). The associated price target ...
MassDevice
1d
Intuitive loses bid for midtrial end to antitrust case
A federal judge rejected Intuitive's request to end an antitrust trial. The case involves third-party servicing of robotic surgery tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback